FDA Approved: DAPTOMYCIN — Original Application (Eugia US LLC)

View source ↗

Summary

FDA approved the original application for daptomycin for Eugia US LLC, authorizing clearance of a generic daptomycin product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacteremia
• Complicated Skin and Skin Structure Infections
• Infective Endocarditis

Drugs mentioned

• Daptomycin (daptomycin)

Snippet

ORIG AP for DAPTOMYCIN (DAPTOMYCIN)